Niobium Microsystems | $23,000,000 | (Dec 10, 2025)
Corma | $4,069,327 | (Dec 10, 2025)
Scowtt | $12,000,000 | (Dec 10, 2025)
Certified by Founder
Lodge
Brixton Biosciences
start up
United States
- Cambridge, MA
- 15/05/2024
- Series B
- $33,000,000
Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for chronic and acute pain.
- Industry Biotechnology Research
- Website https://www.brixtonbio.com/
- LinkedIn https://www.linkedin.com/company/brixtonbiosciences/
AnySignal | $24,000,000 | (Dec 10, 2025)
AllScale | $5,000,000 | (Dec 10, 2025)
CoreOps.AI | $3,500,000 | (Dec 10, 2025)
BON Credit | $3,500,000 | (Dec 10, 2025)
Opine | $5,000,000 | (Dec 10, 2025)
Rotostitch | $1,000,000 | (Dec 10, 2025)
Lin Health | $11,000,000 | (Dec 10, 2025)
Diald AI | $3,750,000 | (Dec 10, 2025)
Tuhk Inc. | $6,000,000 | (Dec 10, 2025)